Unknown

Dataset Information

0

Targeting of cell-free DNA by DNase I diminishes endothelial dysfunction and inflammation in a rat model of cardiopulmonary bypass.


ABSTRACT: The use of cardiopulmonary bypass (CPB) results in the activation of leukocytes, release of neutrophil extracellular traps (NETs) and severe inflammation. We hypothesize that targeting of circulating cell-free DNA (cfDNA) by DNases might represent a feasible therapeutic strategy to limit CPB-associated side effects. Male Wistar rats (n?=?24) underwent CPB with deep hypothermic circulatory arrest (DHCA) and were divided into 3 groups: control (group 1), one i.v. bolus DNase I before CPB start (group 2) and a second DNase I dose before reperfusion (group 3). We found a positive correlation between plasma cfDNA/NETs levels and compromised endothelial vasorelaxation after CPB. DNase I administration significantly diminished plasma cfDNA/NETs levels. Further, a dose-dependent improvement in endothelial function accompanied by significant reduction of circulating intercellular adhesion molecule (ICAM)-1 was observed. Rats of group 3 had significantly reduced plasma IL-6 levels and downregulated expression of adhesion molecules resulting in impaired leukocyte extravasation and reduced MPO activity in lungs. Mechanistically, digestion of NETs by DNase I significantly diminished NETs-dependent upregulation of adhesion molecules in human endothelial cells. Altogether, systemic DNase I administration during CPB efficiently reduced cfDNA/NETs-mediated endothelial dysfunction and inflammation and might represents a promising therapeutic strategy for clinical practice.

SUBMITTER: Weber C 

PROVIDER: S-EPMC6917735 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting of cell-free DNA by DNase I diminishes endothelial dysfunction and inflammation in a rat model of cardiopulmonary bypass.

Weber Carolyn C   Jenke Alexander A   Chobanova Vasilena V   Yazdanyar Mariam M   Chekhoeva Agunda A   Eghbalzadeh Kaveh K   Lichtenberg Artur A   Wahlers Thorsten T   Akhyari Payam P   Paunel-Görgülü Adnana A  

Scientific reports 20191217 1


The use of cardiopulmonary bypass (CPB) results in the activation of leukocytes, release of neutrophil extracellular traps (NETs) and severe inflammation. We hypothesize that targeting of circulating cell-free DNA (cfDNA) by DNases might represent a feasible therapeutic strategy to limit CPB-associated side effects. Male Wistar rats (n = 24) underwent CPB with deep hypothermic circulatory arrest (DHCA) and were divided into 3 groups: control (group 1), one i.v. bolus DNase I before CPB start (gr  ...[more]

Similar Datasets

| S-EPMC8098768 | biostudies-literature
| S-EPMC4127984 | biostudies-literature
| S-EPMC9408928 | biostudies-literature
| S-EPMC10838087 | biostudies-literature
| S-EPMC8754258 | biostudies-literature
| S-EPMC5432426 | biostudies-literature
| S-EPMC7236599 | biostudies-literature
| S-EPMC6037548 | biostudies-literature
| S-EPMC4231204 | biostudies-literature
2010-05-27 | E-GEOD-924 | biostudies-arrayexpress